摘要 |
A compound represented by the following general formula [I] or its pharmaceutically acceptable salt or ester, an Aurora-A selective inhibitor or an anticancer agent containing the same, and the combined use of the above anticancer agent with another anticancer agent: [I] wherein m<SUB>1</SUB> and m<SUB>2</SUB> represent each 1, 2 or 3; n<SUB>1</SUB> and n<SUB>2</SUB> represent each 0 or 1; i is an integer of from 1 to m<SUB>1</SUB>; j is an integer of from 1 to m<SUB>2</SUB>; R represents optionally substituted aryl, heteroaryl or cycloalkyl; R<SUB>al</SUB> and R<SUB>al'</SUB> represent each hydrogen, etc.; R<SUB>bj</SUB> and R<SUB>bj'</SUB> represent each hydrogen, etc.; R<SUB>c</SUB>, R<SUB>d</SUB> and R<SUB>e</SUB> represent each hydrogen, etc.; X<SUB>1</SUB> represents CH, CX<SUB>1a</SUB> or N; X<SUB>2</SUB> represents CH, N, etc.; X<SUB>3</SUB> represents CH, N, etc.; X<SUB>4</SUB> represents CH, N, etc.; Y<SUB>1</SUB>, Y<SUB>2</SUB> and Y<SUB>3</SUB> are the same or different and each represents CH or N; Z<SUB>1</SUB> and Z<SUB>2</SUB> are the same or different and each represents CH or N; and W represents a 5-membered aromatic heterocycle such as pyrazole or thiazole. |
申请人 |
BANYU PHARMACEUTICAL CO., LTD.;OHKUBO, MITSURU;KATO, TETSUYA;KAWANISHI, NOBUHIKO;MITA, TAKASHI;SHIMOMURA, TOSHIYASU |
发明人 |
OHKUBO, MITSURU;KATO, TETSUYA;KAWANISHI, NOBUHIKO;MITA, TAKASHI;SHIMOMURA, TOSHIYASU |